Market Tracker

09/01 6:05pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

24.64
Data as of Aug 29
 -0.01 / -0.04%
Today’s Change
19.39
Today|||52-Week Range
31.04
-1.99%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close24.65
Today’s open24.66
Day’s range24.44 - 24.83
Volume226,881
Average volume (3 months)708,650
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+43.77%
Earnings growth (next 5 years)+26.24%
Revenue growth (last year)-12.07%
P/E ratio1,232.0
Price/Sales3.29
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.33+0.36%
RAREUltragenyx Pharmaceu...-0.51-0.95%
IRWDIronwood Pharmaceuti...+0.29+2.29%
MDCOMedicines Co+0.36+1.43%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.32
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts